Effectiveness of Shuddhabala Taila Matra Vasti on Polycystic ovary syndrome
Department oF Kaumarabrithya and Stree Roga, Faculty of Indigenous Medicine, Gampaha Wickramarachchi University of Indigenous Medicine, Yakkala, Sri Lanka
Research Article
GSC Advanced Research and Reviews, 2023, 14(01), 069-077.
Article DOI: 10.30574/gscarr.2023.14.1.0347
Publication history:
Received on 27 November 2022; revised on 06 January 2023; accepted on 09 January 2023
Abstract:
Polycystic ovary syndrome (PCOS) is a common hormonal abnormality found in women worldwide. Rotterdam criteria is used to diagnose the PCOS. Polycystic Ovarian Syndrome is characterized by excessive production of androgen, and it interfere with ripening of ovarian follicles and aetiology is not known. A Clinical Study was carried out to find out the effectiveness of Shuddhabala Taila Matra Vasti in case of polycystic ovary syndrome, at special subfertility clinic, Gampaha Wickramarachchi Ayurveda teaching hospital. Sixty PCOS patients were randomly selected according to inclusion, exclusion and diagnostic criteria and randomly divided in to two groups as group A and B. Group A were treated with oral drugs and Group B treated with oral drugs and Matra Vasti for one month, after taking the written consent. Kanchanara guggulu and Punarnawashtaka Panta were used as oral drugs and Shudhabala Taila was used for Matra Vasti. Data was collected through an interview-based questionnaire and findings of day 12 Trans-Vaginal Scan Reports. Data was analysed by using Wilcoxon sign rank test and Mann-Whitney U tests. According to the data, Acne identified as the most common symptom (65%) and hirsutism and boldness were identified as the least common symptoms (51.66%) related to this study. When comparing the treatment efficacy between group A (only oral drug treatment) and group B (oral drugs with Vasti treatment), it shows that the treatment of group B was significantly effective for Polycystic Ovarian Syndrome with respect to Oligomenorrhea and Dysmenorrhea, while it (treatment of group B) has not shown a significant efficacy over the group A (oral drug treatment) with respect to improvement of endometrial thickness and Follicular maturity, in Polycystic Ovarian Syndrome at 5 percent level of significance.
Keywords:
Polycystic ovarian syndrome; Oligo menorrhea; Ayurveda; Subfertility
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
